The Carlat Psychiatry Podcast

The Carlat Psychiatry Podcast


A New FDA Approval Brings New Psychiatric Risks

September 01, 2025

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.


CME: Take the CME Post-Test for this Episode

Published On: 09/01/2025

Duration: 16 minutes, 42 seconds


Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.